61 results
20-F
2014 FY
EX-12.2
ENLV
Enlivex Therapeutics Ltd
31 Mar 15
Annual report (foreign)
12:00am
are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether
20-F/A
EX-12.2
vrw7k7c60w031z8coa
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
95igabe8c ylx6m5oyt5
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
8r9ncqe1 mdat6
31 Jan 20
Annual report (foreign) (amended)
4:31pm